GHK-Cu copper tripeptide lyophilized vial — OMNIPOTENT ≥99% HPLC research reference compound for skin biology, collagen, and extracellular matrix research in India

GHK-Cu Skin Biology Research: Collagen, Elastin & Extracellular Matrix Studies (India 2026)

GHK-Cu is the most cited tripeptide in the published skin-biology and extracellular-matrix research literature of the last two decades. Originally characterised by Pickart and colleagues in the 1970s as a copper-binding peptide from human plasma, it has since accumulated hundreds of published in-vitro studies on fibroblast biology, collagen synthesis, elastin production, MMP/TIMP balance, and wound-healing pathways. This 2026 reference summarises what the actual literature shows — not what cosmetic marketing claims — for India dermatology researchers, biohackers, and laboratory buyers.

TL;DR

  • Compound: Copper-complexed tripeptide Gly-His-Lys + Cu(II). CAS 89030-95-5.
  • Most-cited skin research areas: dermal fibroblast biology, collagen I and III synthesis, elastin gene expression, MMP-2 / MMP-9 regulation, TIMP expression, wound-healing models.
  • Published in-vitro observations: GHK-Cu has been studied in cultured human dermal fibroblasts where multiple references have observed effects on ECM-protein gene expression and MMP/TIMP balance. The translation to in-vivo human outcomes is an active research question.
  • Research-grade reference: OMNIPOTENT GHK-Cu, HPLC ≥99%, batch COA, lyophilised. ₹7,499 (50 mg) / ₹11,999 (100 mg).

The skin extracellular matrix — quick context

To follow the research literature on GHK-Cu and skin, here's the minimum ECM-biology background:

  • The dermal extracellular matrix is dominated by type I and type III collagen, elastin, glycosaminoglycans (hyaluronic acid, dermatan sulfate, etc.), and various structural proteoglycans.
  • The cell type that synthesises most of these is the dermal fibroblast. Most published GHK-Cu skin research uses cultured human dermal fibroblasts as the primary model system.
  • MMPs (matrix metalloproteinases) degrade ECM proteins; TIMPs (tissue inhibitors of metalloproteinases) inhibit MMPs. The balance between them determines ECM turnover rate, and dysregulation is referenced in the published aging-skin literature.
  • Lysyl oxidase (LOX) is a copper-dependent enzyme that cross-links collagen and elastin. This is one reason copper-coordinating peptides like GHK-Cu are studied specifically in ECM contexts.

Published research: GHK-Cu and dermal fibroblasts

The fibroblast literature on GHK-Cu spans multiple decades and is the most extensive body of published research on the molecule. Key referenced areas:

Cell proliferation and viability

Multiple in-vitro studies have observed GHK-Cu effects on cultured fibroblast proliferation in published research. The Pickart and Margolina reviews summarise this literature; concentrations studied are typically in the nanomolar to low-micromolar range.

Collagen synthesis

A consistent observation in the published in-vitro literature is increased gene expression of type I collagen (COL1A1) and type III collagen (COL3A1) in cultured human dermal fibroblasts exposed to GHK-Cu at studied concentrations. Effects on procollagen protein synthesis have also been published.

Elastin and other ECM proteins

Published research has observed effects of GHK-Cu on elastin (ELN) gene expression and on decorin and other small leucine-rich proteoglycans in cultured fibroblasts.

MMP / TIMP balance

Published in-vitro studies have observed referenced effects on MMP-2 and MMP-9 expression and on TIMP-1 and TIMP-2 expression in fibroblast culture systems. The published rationale is that copper-coordinating peptides may modulate ECM-remodelling enzymes via copper-dependent metallo-enzyme interactions.

Published research: GHK-Cu and wound healing

Wound-healing models — both in-vitro scratch assays and in-vivo animal model studies — are the second-largest body of published GHK-Cu research after fibroblast culture work.

  • In-vitro scratch-wound assays: published observations of accelerated cell-migration closure in dermal fibroblast and keratinocyte monolayers exposed to GHK-Cu at studied concentrations.
  • Animal-model wound studies: published research in rodent skin-wound and burn-wound models has observed effects on wound contraction rate, collagen deposition, and angiogenic markers in some published protocols.
  • Combinatorial wound-healing research: GHK-Cu is frequently studied alongside TB-500 and BPC-157 in published combinatorial wound-healing literature — which is part of the rationale for the KLOW 4-in-1 blend.

Published research: GHK-Cu and skin-aging markers

The "anti-aging" framing in the published research literature is more nuanced than cosmetic marketing makes it sound. Key research observations:

  • Published gene-expression profiling studies have referenced GHK-Cu effects on multiple pathways relevant to dermal aging — including DNA-repair gene families, antioxidant response elements, and collagen-synthesis genes in cultured cells.
  • Photoaging models: published in-vitro photo-damage research has observed effects of GHK-Cu pre-treatment on UVB-induced gene-expression changes in keratinocytes and fibroblasts.
  • Glycation studies: published in-vitro research has observed referenced effects on advanced-glycation-end-product formation in collagen models.

These are in-vitro observations. Translating them to human in-vivo "anti-aging" outcomes is the gap that genuine clinical research is still trying to close. We make no therapeutic or cosmetic claim about GHK-Cu — it is sold strictly as a research reference compound.

Why Cu(II) coordination matters in skin research

Many of the published skin-biology research observations on GHK-Cu depend specifically on the copper-complexed form, not on the bare GHK peptide. Reasons in the literature:

  • Lysyl oxidase, the copper-dependent ECM cross-linking enzyme, is referenced in published research as one mechanism by which copper-coordinating peptides may affect dermal collagen and elastin maturation.
  • Cellular copper handling involves multiple chaperones and transporters. GHK-Cu has been studied in the published literature as a vehicle that can deliver copper to specific cellular compartments in a controlled fashion.
  • Reactive oxygen species (ROS) chemistry is sensitive to copper coordination. The published in-vitro literature has examined GHK-Cu's redox behaviour in fibroblast culture systems.

For the deeper copper-coordination chemistry, see our copper peptide chemistry deep dive.

Research-grade GHK-Cu vs cosmetic copper peptide — skin research specifically

Cosmetic copper-peptide serums are not interchangeable with research-grade GHK-Cu for laboratory skin research. The reasons:

  • Active concentration: Cosmetic serums typically contain fractions of a percent of GHK-Cu. A 1 ml application contains far less peptide than even a single nanomolar in-vitro experiment would require.
  • Excipients confound assays: Cosmetic formulations contain humectants, emollients, preservatives, and fragrance compounds that can themselves affect fibroblast assays — making it impossible to attribute observed effects to the GHK-Cu alone.
  • No batch-specific COA: Cosmetic vendors do not publish HPLC purity or per-batch peptide content. Research integrity requires that you know what you're putting in your assay.
  • Stability: Pre-formulated cosmetic serums have shelf-life concerns that lyophilised research powder does not.

For laboratory work, source research-grade lyophilised vials with HPLC ≥99% and batch COA. For cosmetic-use comparisons, that's a separate consumer product category.

What India dermatology research labs study in 2026

  • India-population fibroblast characterisation: Establishing in-vitro Indian-skin-type-derived fibroblast lines and benchmarking GHK-Cu responses against the established US/Korean literature.
  • Analytical method development: HPLC and LC-MS protocols for quantifying GHK-Cu in formulation studies and for batch-QA work on cosmetic and pharmaceutical formulations.
  • Combinatorial ECM research: In-vitro studies pairing GHK-Cu with TB-500, BPC-157, and KPV (the KLOW components) on dermal fibroblast and 3D skin-equivalent models.
  • Stability under Indian-climate stress: Characterising Cu(II) coordination behaviour and peptide degradation at the temperatures typical of Indian climate (35–45 °C summers).
  • Photoaging research: In-vitro photo-damage protocols using India-relevant UV-exposure profiles.

Storage and reconstitution for skin-research protocols

  • Sealed vial storage: 2–8 °C, protected from light.
  • Reconstitution: Bacteriostatic Water (0.9% benzyl alcohol). For in-vitro fibroblast work, some protocols use sterile water for injection or PBS instead — check your protocol.
  • Working concentration: Most published fibroblast studies use 10 nM to 10 µM range. From a 50 mg vial reconstituted to 10 mg/ml stock, serial dilutions cover this range easily.
  • Post-reconstitution stability: Refrigerated, light-protected; the Cu(II) chromophore makes the solution sensitive to oxidation — minimise air contact.

Full protocol in our peptide reconstitution lab guide.

India sourcing — GHK-Cu price benchmarks 2026

  • Fair INR range, 50 mg lyophilised vial: ₹6,500 – ₹10,000
  • Fair INR range, 100 mg lyophilised vial: ₹10,000 – ₹14,000
  • OMNIPOTENT 50 mg: ₹7,499 | 100 mg: ₹11,999

Cosmetic copper-peptide serums on Nykaa or Amazon are not equivalent and should not be treated as such for laboratory work — see the comparison section above.

FAQ

Does GHK-Cu increase collagen synthesis?
In the published in-vitro fibroblast literature, GHK-Cu has been observed to affect collagen gene expression and protein synthesis at studied concentrations. Whether this in-vitro observation translates to clinically meaningful in-vivo collagen production is an active research question, and we make no therapeutic claim.

Is GHK-Cu the same as Matrixyl or Argireline?
No. Matrixyl (palmitoyl pentapeptide-4) and Argireline (acetyl hexapeptide-3) are different synthetic peptides in cosmetic research. They share the broad "peptide skincare" category but are chemically distinct from GHK-Cu.

Which copper peptide is the most studied?
GHK-Cu is by far the most-cited copper-coordinating peptide in the published skin-research literature. Other copper peptides exist but have much smaller research bases.

What concentration is used in published fibroblast research?
Common ranges in published in-vitro studies are 10 nM to 10 µM, depending on the experimental endpoint. For a 50 mg vial reconstituted to 10 mg/ml, you can prepare stock dilutions covering this entire range.

Where do India dermatology labs source GHK-Cu?
OMNIPOTENT dispatches lyophilised research-grade GHK-Cu from within India, HPLC ≥99%, with batch-specific COA on request.

Related research peptides and articles

Disclaimer: This article is provided for informational and research-literature context only. GHK-Cu is supplied strictly as a chemical reference standard for in-vitro laboratory research and analytical method development. It is not a drug, food, cosmetic, or supplement and is not approved for human or veterinary use by CDSCO, FSSAI, the US FDA, or any other regulatory body. References to published in-vitro studies are research observations, not therapeutic or cosmetic claims. By placing an order the purchaser affirms compliance with the Drugs and Cosmetics Act 1940, the Food Safety and Standards Act 2006, the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954, and any applicable regulations.

Back to blog